
Building a modern operating system for IVF, powered by artificial intelligence.
What they do: AI-driven software to optimize IVF workflows and embryo selection
Founded / HQ: 2020; San Francisco
Recent leadership: Melissa Teran appointed CEO (Oct 10, 2024); Paxton Maeder-York transitioned to board
Funding: Seed $9.5M (May 2021); Series A $22M (Mar 22, 2022)
Notable investors: Lux Capital, Union Square Ventures, Maveron
| Company |
|---|
Clinical decision support and workflow optimization for in vitro fertilization (IVF).
2020
Fertility technology / reproductive health
$9.5M
$22M
“Backed by venture investors including Lux Capital, Union Square Ventures and Maveron”